Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/2
60
about 4.9 years
18–55
1 site in PA
What this study is about
Researchers are testing whether acetazolamide helps people with schizophrenia who haven't responded well to other treatments. It involves comparing acetazolamide to a placebo (an inactive pill). The trial will last about 1793 days and involve approximately 60 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Acetazolamide
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
acetazolamide
injection, intravenous
Primary: Change in positive symptoms
Secondary: Cognition, Measure of satisfaction with one's Quality of Life (Quality of Life Scale/QOLS)
Psychiatry / Mental Health